Reference Population for Speckle Tracking Imaging — STE Normal

Left Ventricular Function Clinical Trial

Official title:
Establishing a Reference Population for Normal Left Ventricular Function Parameters to Validate the Use of Two Dimensional Speckle Tracking Imaging Software in the Scar Study

Status Completed

Clinical Trial Summary

The SCAR study uses a software program entitled QLAB, a proprietory program, developed by Philips Healthcare (Philips Healthcare, Andover, MA). Literature on two-dimensional speckle tracking imaging (2DSTE) is growing, but data relevant to the population in the SCAR study is minimal. Accumulation of data relevant for a population of subjects will provide a set of normal values for interpretation of 2DSTE and minimize any influences from differences in data produced from different companies. This data may also assist other researchers investigate other cardiac diseases and abnormalities.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Left Ventricular Function

Clinical Trial Details

NCT number	NCT01526252
Study type	Observational
Source	Ottawa Heart Institute Research Corporation
Contact
Status	Completed
Phase	N/A
Start date	December 2011
Completion date	January 2015

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02608567` - Prognostic Impact of Myocardial Longitudinal Strain in Asymptomatic Aortic Stenosis: a Meta-Analysis	N/A
Active, not recruiting	`NCT01515267` - Automated Left Ventricular Function Evaluation by LVivoEF	N/A
Completed	`NCT04228874` - Effect of Stent Size on Dyssynchrony